Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/41709

Title:	Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
Authors:	de Velasco, Guillermo Culhane, Aedín C Fay, André P Hakimi, A Ari Voss, Martin H Tannir, Nizar M Tamboli, Pheroze Appleman, Leonard J Bellmunt, Joaquim Kimryn Rathmell, W Albiges, Laurence Hsieh, James J Heng, Daniel Y C Signoretti, Sabina Choueiri, Toni K View more
Keywords:	Genomics Prognosis Signature TCGA mRCC View more
Mesh:	Aryl Hydrocarbon Receptor Nuclear Translocator Basic Helix-Loop-Helix Transcription Factors Carcinoma, Renal Cell Cohort Studies Databases, Factual Disease-Free Survival Female Gene Expression Regulation, Neoplastic Humans Male Neoplasms, Second Primary Risk Factors Molecular Targeted Therapy Prognosis View more
Issue Date:	2017
Citation:	Oncologist.2017 03;(22)3:286-292
Abstract:	Gene-expression signatures for prognosis have been reported in localized renal cell carcinoma (RCC). The aim of this study was to test the predictive power of two different signatures, ClearCode34, a 34-gene signature model [Eur Urol 2014;66:77-84], and an 8-gene signature model [Eur Urol 2015;67:17-20], in the setting of systemic therapy for metastatic disease.
PMID:	28220024
URI:	https://hdl.handle.net/20.500.12530/41709
Rights:	openAccess
Appears in Collections:	Hospitales > H. U. 12 de Octubre > Artículos

Files in This Item:

File	Description	Size	Format
PMC5344647.pdf		501.27 kB	Adobe PDF	View/Open